Truist Financial Corp Adma Biologics, Inc. Transaction History
Truist Financial Corp
- $61.3 Billion
- Q1 2025
A detailed history of Truist Financial Corp transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Truist Financial Corp holds 11,330 shares of ADMA stock, worth $273,166. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,330Holding current value
$273,166% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
351Shares Held
182MCall Options Held
1.72MPut Options Held
846K-
Black Rock Inc. New York, NY18.6MShares$450 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA18.2MShares$439 Million0.01% of portfolio
-
State Street Corp Boston, MA14.9MShares$359 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA11.3MShares$272 Million0.04% of portfolio
-
Morgan Stanley New York, NY5.53MShares$133 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $4.73B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...